|93.58||+0.3000||+0.32%||Vol 3.61M||1Y Perf -27.49%|
|Aug 8th, 2022 16:00 DELAYED|
|- -||-0.33 -0.35%|
|Target Price||113.00||Analyst Rating||Moderate Buy 2.11|
|Potential %||20.75||Finscreener Ranking||★ 41.37|
|Insiders Trans % 3/6/12 mo.||-/-100/-85||Value Ranking||★★+ 48.51|
|Insiders Value % 3/6/12 mo.||-/-100/-96||Growth Ranking||★★★ 51.46|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-100/-95||Income Ranking||★★★+ 46.88|
|Price Range Ratio 52W %||13.99||Earnings Rating||Strong Sell|
|Market Cap||124.34B||Earnings Date||23rd Aug 2022|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||23rd Aug 2022|
|Estimated EPS Next Report||1.12|
|EPS Growth Next 5 Years %||7.00|
|Avg. Weekly Volume||3.74M|
|Avg. Monthly Volume||4.61M|
|Avg. Quarterly Volume||5.44M|
Medtronic plc. (NYSE: MDT) stock closed at 93.58 per share at the end of the most recent trading day (a 0.32% change compared to the prior day closing price) with a volume of 3.61M shares and market capitalization of 124.34B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 90000 people. Medtronic plc. CEO is Geoffrey S. Martha.
The one-year performance of Medtronic plc. stock is -27.49%, while year-to-date (YTD) performance is -9.54%. MDT stock has a five-year performance of 11.47%. Its 52-week range is between 86.7 and 135.89, which gives MDT stock a 52-week price range ratio of 13.99%
Medtronic plc. currently has a PE ratio of 23.90, a price-to-book (PB) ratio of 2.25, a price-to-sale (PS) ratio of 3.69, a price to cashflow ratio of 16.40, a PEG ratio of 2.32, a ROA of 5.84%, a ROC of 6.82% and a ROE of 10.32%. The company’s profit margin is 16.05%, its EBITDA margin is 27.50%, and its revenue ttm is $31.69 Billion , which makes it $23.85 revenue per share.
Of the last four earnings reports from Medtronic plc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $1.12 for the next earnings report. Medtronic plc.’s next earnings report date is 23rd Aug 2022.
The consensus rating of Wall Street analysts for Medtronic plc. is Moderate Buy (2.11), with a target price of $113, which is +20.75% compared to the current price. The earnings rating for Medtronic plc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Medtronic plc. has a dividend yield of 3.09% with a dividend per share of $2.72 and a payout ratio of 87.00%.
Medtronic plc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 5.49, ATR14 : 1.69, CCI20 : 77.28, Chaikin Money Flow : 0.14, MACD : 0.47, Money Flow Index : 61.87, ROC : 4.54, RSI : 64.69, STOCH (14,3) : 84.60, STOCH RSI : 0.73, UO : 58.70, Williams %R : -15.40), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Medtronic plc. in the last 12-months were: Bradley E. Lerman (Option Excercise at a value of $7 633 467), Bradley E. Lerman (Sold 99 922 shares of value $13 033 509 ), Carol A. Surface (Sold 12 000 shares of value $1 263 600 ), Geoffrey S. Martha (Option Excercise at a value of $1 431 610), Geoffrey S. Martha (Sold 23 162 shares of value $3 072 903 ), Karen L. Parkhill (Sold 682 shares of value $75 020 ), Richard H. Anderson (Buy at a value of $517 333), Robert J. White (Sold 7 218 shares of value $736 525 ), Sean Salmon (Option Excercise at a value of $3 300 199), Sean Salmon (Sold 85 257 shares of value $11 431 476 )
Fri, 15 Jul 2022 16:41 GMT Medtronic (MDT) Receives a Hold from Morgan Stanley- TipRanks. All rights reserved.
Tue, 31 May 2022 01:10 GMT Medtronic (MDT) Receives a Hold from Credit Suisse- TipRanks. All rights reserved.
Sat, 28 May 2022 12:10 GMT Medtronic (MDT) Receives a Hold from J.P. Morgan- TipRanks. All rights reserved.
Fri, 27 May 2022 15:40 GMT What Medtronics Earnings Miss Means for Investors- TipRanks. All rights reserved.
Thu, 26 May 2022 19:05 GMT Medtronic (MDT) Gets a Hold Rating from BTIG- TipRanks. All rights reserved.
Tue, 24 May 2022 04:25 GMT Analysts Top Healthcare Picks: Medtronic (MDT), Seagen (SGEN)- TipRanks. All rights reserved.
Wed, 18 May 2022 01:10 GMT Medtronic (MDT) Gets a Hold Rating from Credit Suisse- TipRanks. All rights reserved.
Thu, 07 Apr 2022 09:55 GMT Medtronic (MDT) Gets a Buy Rating from Needham- TipRanks. All rights reserved.
Mon, 24 Jan 2022 17:25 GMT Medtronic: FDA Warning Creates Opportunity- TipRanks. All rights reserved.
Fri, 21 Jan 2022 12:31 GMT Medtronic (MDT) Gets a Hold Rating from Leerink Partners- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.